
Steven J. Burakoff
- DIRECTOR TISCH CANCER INSTITUTE
- PROFESSOR Oncological Sciences
- PROFESSOR Medicine, Hematology and Medical Oncology
Print Profile
Specialty
Certifications
American Board of Internal Medicine
Research Topics
Training Areas
Education
MD, Albany Medical College
MA (hon.), Harvard University
Rockefeller University
Harvard Medical School
MA, Queens College
New York Hospital-Cornell Medical Center
Internship, General Medicine
Cornell Medical CenterResidency, General Medicine
Cornell Medical CenterFellowship, Immunology
Rockefeller University
Biography
- Dr. Burakoff is the Director of The Tisch Cancer Institute at Mount Sinai Medical Center; Lillian and Henry M. Stratton Professor of Cancer Medicine; Professor of Medicine, Hematology and Medical Oncology; and Professor, Oncological Sciences.
Pushing Frontiers in Complex Cancer Care
Awards
2009 -
Lifetime Achievement Award
American Association of Immunologists2006 -
Lynne Cohen Foundation Awardee
2003 -
Distinguished Alumnus 2003
2002 -
Theobold Smith Alumni Lecture
Albany Medical College2001 -
ISI Highly Cited Researcher (1980-2000)
2000 -
Laura and Isaac Perlmutter Professor
New York University, School of Medicine1998 -
Margaret M. Dyson Professor of Pediatrics
Harvard Medical School1995 -
Association of American Physicians
1995 -
Ted Williams Senior Investigator
Dana-Farber Cancer Institute1994 -
Horizons in Biomedical Research Lecture
Cleveland Clinic Foundation1992 -
David A. Talmadge Lecture
Colorado Allergy Society
Research
Major Research Interests:1. Cellular and molecular immunology;
2. T cell activation and signal transduction;
3. Transplantation immunology.
Publications
Jin YJ, Cai CY, Zhang X, Zhang HT, Burakoff SJ. Lysine144, a Ubiquitin Attachment Site in HIV-1 Nef, Is Required for Nef-mediated CD4 Downregulation. J Immunol 2008;.
Sawasdikosol S, Pyarajan S, Alzabin S, Matejovic G, Burakoff SJ. Prostaglandin E2 activates HPK1 activity via a PKA-dependent pathway. J Biol Chem 2007 Nov; 282: 34693-34699.
Mathews JP, Taylor BS, Bader GD, Pyarajan S, Antoniotti M, Chinnaiyan AM, Sander C, Burakoff SJ, Mishra B. From bytes to bedside: data integration and computational biologyfor translational cancer research. PLoS Comput Biol 2007 Feb 23; 3(2): e12.
Fragoso R, Pyarajan S, Irie HY, Burakoff SJ. CD8/Lck transgene is able to drive thymocyte differentiation. J. Immun 2006 Feb 15; 176(4): 2669.
Jin JJ, Yi Cai C, Zhang X, Zhang HT, Hirst JA, Burakoff SJ. HIV Nef-mediated CD4 down-regulation is adaptor protein complex 2 dependent. J. Immun 2006 Feb 15; 176(4): 2669.
Zambricki E, Shigeoka A, Kishimoto H, Sprent J, Burakoff S, Carpenter C, Milford E, McKay D. Signaling T cell survival and death by IL-2 and IL-15. Am J Transplant 2005; 11: 2623-2631.
Su MW, Pyarajan S, Chang JH, Yu CL, Jin YJ, Stierhof YD, Walden P, Burakoff SJ. Fratricide of CD8+ cytotoxic T Lymphocytes is dependent on cellular activation and perforin-mediated killing. Eur J Immunol 2004; 34: 2459-2470.
Frazer-Abel AA, Baksh S, Fosmire SP, Willis D, Pierce AM, Meylemans H, Linthicum DS, Burakoff SJ, Coons T, Bellgrau D. Nicotine activates NFATc2 and prevents cell cycle entry in T cells. J Pharmacol Exp Ther 2004; 311: 758-769.
Friedman JS, Alpdogan O, van den Brink MR, Liu C, Hurwiz D, Boyd A, Kupper TS, Burakoff SJ. Increasing T cell age reduces effector activity but preserves proliferative capacity in a murine allogeneic major histocompatibility complex-mismatched bone marrow transplant model. Biol Blood Marrow Transplant 2004; 10: 448-460.
Friedman JS, Lopez MF, Fleming MD, Rivera A, Martin FM, Welsh ML, Boyd AS, Doctrow SR, Burakoff SJ. SOD2 Deficiently anemia: protein oxidation and altered protein expression reveal targets of damage, stress response and anti -oxidant responsiveness. Blood 2004; 104: 2565-2573.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Burakoff during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Cold Spring Harbor Laboratory (CSHL)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Icahn Medical Institute Floor 1st fl- Suite 100 Room L1-15C
1425 Madison Avenue
New York, NY 10029
One Gustave L. Levy Place
Box 1128
New York, NY 10029
Fax: 212-241-9244


